Company: ABUS
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001140361-25-012305
Chunk: 47

Company: Arbutus Biopharma Corp
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 47
---
,000 |     |                |       — |     |               | $5.20 |     |           | 4/16/2028 |     |            |
|                         |         |     |                 |          |     |                 | 145,000 |     |                |       — |     |               | $4.57 |     |           | 3/1/2029  |     |            |
|                         |         |     |                 |          |     |                 | 250,000 |     |                |       — |     |               | $3.35 |     |           | 2/17/2030 |     |            |
|                         |         |     |                 |          |     |                 | 277,917 |     |                |       — |     |               | $4.33 |     |           | 2/13/2031 |     |            |
|                         |         |     |                 |          |     |                 | 207,813 |     |                |       — |     |               | $2.81 |     |           | 1/20/2032 |     |            |
|                         |         |     |                 |          |     |                 | 150,654 |     |                |       — |     |               | $2.90 |     |           | 2/1/2033  |     |            |
|                         |         |     |                 |          |     |                 |  91,208 |     |                |       — |     |               | $2.40 |     |           | 2/1/2034  |     |            |

| (1) | The shares underlying these restricted stock units vest in three equal annual installments, subject to continued service to us through each vesting date. |

29

TABLE OF CONTENTS

| (2) | Market Value was calculated based upon the $3.27 closing share price on December 31, 2024. |

| (3) | Options granted after February 5, 2014 through December 31, 2019 vested (or remain eligible to vest) in thirds on each of the first three anniversaries of their grant date. Options granted after January 1, 2020 vested (or remain eligible to vest) 1/48th each month over a four-year period after the grant date. |

| (4) | Options expire 10